{"id":"https://openalex.org/W1982916435","doi":"https://doi.org/10.1111/j.1476-5381.1977.tb07506.x","title":"EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5\u2010HYDROXYTRYPTAMINE","display_name":"EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5\u2010HYDROXYTRYPTAMINE","publication_year":1977,"publication_date":"1977-07-01","ids":{"openalex":"https://openalex.org/W1982916435","doi":"https://doi.org/10.1111/j.1476-5381.1977.tb07506.x","mag":"1982916435","pmid":"https://pubmed.ncbi.nlm.nih.gov/890205","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1667291"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1977.tb07506.x","doi":"https://doi.org/10.1111/j.1476-5381.1977.tb07506.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1977.tb07506.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1977.tb07506.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1982916435"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1977.tb07506.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033990182","display_name":"A.R. GREEN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A.R. GREEN","raw_affiliation_strings":["MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089756890","display_name":"Brian Mitchell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B.D. MITCHELL","raw_affiliation_strings":["MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076155114","display_name":"Ann F.C. Tordoff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"ANN F.C. TORDOFF","raw_affiliation_strings":["MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053858269","display_name":"Moussa B. H. Youdim","orcid":"https://orcid.org/0000-0002-1361-3872","observed_orcids":["https://orcid.org/0000-0002-1361-3872"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M.B.H. YOUDIM","raw_affiliation_strings":["MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HE","institution_ids":["https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I40120149"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.9764,"has_fulltext":true,"cited_by_count":152,"citation_normalized_percentile":{"value":0.71067961,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"60","issue":"3","first_page":"343","last_page":"349"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9326000213623047,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9326000213623047,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.02810000069439411,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.01489999983459711,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoamine-oxidase-a","display_name":"monoamine oxidase A","score":0.796999990940094},{"id":"https://openalex.org/keywords/monoamine-oxidase-b","display_name":"monoamine oxidase B","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tranylcypromine","display_name":"tranylcypromine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/clorgyline","display_name":"clorgyline","score":0.9909999966621399},{"id":"https://openalex.org/keywords/selegiline","display_name":"selegiline","score":0.9269999861717224},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.8880000114440918},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.8960000276565552},{"id":"https://openalex.org/keywords/phenylethylamine","display_name":"phenylethylamine","score":0.9010000228881836},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/brain-monoamine-metabolism","display_name":"brain monoamine metabolism","score":0.5799999833106995},{"id":"https://openalex.org/keywords/hyperactivity","display_name":"hyperactivity","score":0.5860000252723694},{"id":"https://openalex.org/keywords/tryptophan","display_name":"tryptophan","score":0.7170000076293945},{"id":"https://openalex.org/keywords/brain-catecholamines","display_name":"brain catecholamines","score":0.4869999885559082},{"id":"https://openalex.org/keywords/enzyme-inhibition","display_name":"enzyme inhibition","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C2777118369","wikidata":"https://www.wikidata.org/wiki/Q420885","display_name":"Tranylcypromine","level":4,"score":0.9551451802253723},{"id":"https://openalex.org/C2910293678","wikidata":"https://www.wikidata.org/wiki/Q2889652","display_name":"Clorgyline","level":4,"score":0.9287208318710327},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.8551254868507385},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.7422524094581604},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6355600357055664},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5764825940132141},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5341407656669617},{"id":"https://openalex.org/C39398028","wikidata":"https://www.wikidata.org/wiki/Q18028862","display_name":"Monoamine oxidase B","level":4,"score":0.5122763514518738},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.4741054177284241},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.46697306632995605},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.4611980617046356},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4546617865562439},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20132926106452942},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19874700903892517},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17865046858787537},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15983781218528748},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D001923","descriptor_name":"Brain Chemistry","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003010","descriptor_name":"Clorgyline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003641","descriptor_name":"Deamination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008995","descriptor_name":"Monoamine Oxidase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014191","descriptor_name":"Tranylcypromine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014364","descriptor_name":"Tryptophan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1977.tb07506.x","doi":"https://doi.org/10.1111/j.1476-5381.1977.tb07506.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1977.tb07506.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1977.tb07506.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:890205","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/890205","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1667291","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1667291/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1977.tb07506.x","doi":"https://doi.org/10.1111/j.1476-5381.1977.tb07506.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1977.tb07506.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1977.tb07506.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1982916435.pdf","grobid_xml":"https://content.openalex.org/works/W1982916435.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1492303002","https://openalex.org/W1551843367","https://openalex.org/W1775749144","https://openalex.org/W1910733505","https://openalex.org/W1990784490","https://openalex.org/W1995790835","https://openalex.org/W2004895078","https://openalex.org/W2013482285","https://openalex.org/W2021936798","https://openalex.org/W2050480334","https://openalex.org/W2080876709","https://openalex.org/W2082724832","https://openalex.org/W2122186046","https://openalex.org/W2152571675","https://openalex.org/W6929699960","https://openalex.org/W7214201014"],"related_works":["https://openalex.org/W2152571675","https://openalex.org/W2043270340","https://openalex.org/W1981632678","https://openalex.org/W239116238","https://openalex.org/W19035109","https://openalex.org/W2049747629","https://openalex.org/W2036751946","https://openalex.org/W2034423774","https://openalex.org/W2148153854","https://openalex.org/W2038812160"],"abstract_inverted_index":{"1":[0],"Tranylcypromine":[1],"(20":[2,161],"mg/kg)":[3,28,56,72,162,225,263],"administration":[4,57],"to":[5,171],"rats":[6,45],"totally":[7,75,122,397],"inhibited":[8,58,76,80,123,398],"brain":[9,36,97,136,164,195,252,276],"monoamine":[10],"oxidase":[11],"(MAO)":[12],"oxidation":[13,60,78,124,340],"of":[14,87,113,119,125,135,159,302,315,317,338,341,368,415],"5\u2010hydroxytryptamine":[15],"(5\u2010HT),":[16],"phenylethylamine":[17,65,77,127,334],"and":[18,38,43,50,79,102,128,138,141,151,167,189,200,212,247,278,289,323,330,343,363,365,381,387,406],"dopamine":[19,37,98,137,166,196,277,324,342,374,405],"as":[20,325,335,410],"measured":[21],"in":[22,251,275,385,404],"vitro.":[23],"When":[24,222,260],"l\u20103,4\u2010dihydroxyphenylalanine":[25],"(l\u2010DOPA)":[26],"(50":[27,224,262],"was":[29,131,226,254,264,327,345],"given":[30,227,265],"30":[31],"min":[32],"after":[33,89,174,187,231,245,269,309,350,371],"the":[34,44,103,142,145,233,291,306,313,318,359,366,413,416],"tranylcypromine,":[35,372],"noradrenaline":[39,100,139,168,209,279],"concentrations":[40,101,140,169,180,197],"rose":[41,198],"markedly":[42],"displayed":[46,144],"characteristic":[47,234],"behavioural":[48,109,146,292],"changes":[49,147,293],"locomotor":[51],"activity.":[52],"2":[53],"Clorgyline":[54],"(5":[55,71,117],"5\u2010HT":[59,81,179,253,322,344,407],"by":[61,66,83,377,412],"almost":[62,74,121,396],"100%":[63],"but":[64,241,284],"only":[67,84,255,296,391],"29%":[68],"while":[69,208],"(\u2010)\u2010deprenil":[70,116],"injection":[73,175,188],"metabolism":[82],"31%.":[85],"Administration":[86,112],"l\u2010DOPA":[88,152,261],"pretreatment":[90],"with":[91,321,333,361],"either":[92],"drug":[93],"did":[94,105],"not":[95,106,242,285],"alter":[96],"or":[99],"animals":[104,143],"display":[107],"any":[108],"changes.":[110],"3":[111],"clorgyline":[114,362],"plus":[115],"mg/kg":[118],"each)":[120],"both":[126,358,378,393],"5\u2010HT;":[129],"there":[130,400],"a":[132,248,271],"large":[133,273],"rise":[134,250,274],"observed":[148,256,295],"when":[149,392],"tranylcypromine":[150,160,232,246,270,310,351],"had":[153],"been":[154],"given.":[155],"4":[156],"The":[157],"effects":[158],"on":[163],"5\u2010HT,":[165],"up":[170],"48":[172,206,219],"h":[173,186,207,240,244,283,288,349],"were":[176,181,294],"recorded.":[177],"Brain":[178],"considerably":[182],"elevated":[183],"for":[184,205,218],"18":[185,243,287,348],"then":[190],"fell":[191],"steadily.":[192],"In":[193],"contrast,":[194],"slightly":[199],"remained":[201,214],"at":[202,215,228,238,257,266,281,286,297,305],"this":[203,216],"level":[204,217],"levels":[210],"doubled":[211],"also":[213],"hours.":[220,259,299],"5":[221],"l\u2010tryptophan":[223],"various":[229,267],"times":[230,268,308],"hyperactivity":[235,417],"syndrome":[236],"appeared":[237],"12":[239,258,282,298],"further":[249,272],"occurred":[280],"all":[290],"6":[300],"Measurement":[301],"MAO":[303,339,369,384],"activity":[304,320,370],"above":[307],"showed":[311],"that":[312,373,388,399],"half\u2010life":[314],"recovery":[316,367],"enzyme":[319],"substrates":[326],"4.5":[328],"days":[329,332],"8.5":[331],"substrate.":[336],"Inhibition":[337],"approximately":[346],"85%,":[347],"injection.":[352],"7":[353],"It":[354],"is":[355,375,390,401],"concluded":[356],"from":[357],"studies":[360],"deprenil":[364],"metabolized":[376],"Type":[379,382],"A":[380],"B":[383],"vivo":[386],"it":[389],"forms":[394],"are":[395],"an":[402],"increase":[403],"functional":[408],"activity,":[409],"judged":[411],"appearance":[414],"syndromes.":[418]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
